ArticleMelanoma management2021

BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma.

Karam Khaddour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.